CASTLE CREEK BIOSCIENCES, INC.
Profile
Company Names
CASTLE CREEK BIOSCIENCES, INC.
CASTLE CREEK PHARMACEUTICAL HOLDINGS, INC.
Addresses
405 EAGLEVIEW BOULEVARD, EXTON, PA 19341
6 CENTURY DRIVE, 2ND FLOOR, PARSIPPANY, NJ 07054
Phone Numbers
847-715-0606
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
2018
State Incorporated:
DELAWARE
Total Amount Raised:
$839,779,367.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2025-02-24
$75,000,000.00
$75,000,000.00
$0.00
5
2022-04-19
$112,782,892.00
$112,782,892.00
$0.00
Equity
4
2022-01-18
$11,850,000.00
$11,850,000.00
$0.00
Debt
3
2021-06-28
$25,000,000.00
$25,000,000.00
$0.00
Debt
2
2019-12-09
$54,602,249.00
$54,602,249.00
$0.00
Equity
1
2018-10-09
$560,544,226.00
$560,544,226.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFFREY
ARONIN
DIRECTOR
JEFFREY
S.
ARONIN
DIRECTOR
TIMOTHY
CUNNIFF
DIRECTOR
MICHAEL
DERBY
EXECUTIVE OFFICER, DIRECTOR
ANTONIO
GRACIAS
DIRECTOR
TESLA MOTORS INC
| SPACE EXPLORATION TECHNOLOGIES CORP
| FOODA, INC.
| VALOR EQUITY PARTNERS III L.P.
| VALOR EQUITY PARTNERS III-A L.P.
| PORCH.COM, INC.
| CASTLE CREEK PHARMACEUTICALS, LLC
| HARMONY BIOSCIENCES II, INC.
| BITGO, INC.
| BIRD RIDES, INC.
| HARBOR PLATFORM, INC.
| BITGO HOLDINGS, INC.
| TESLA, INC.
| CLOUD9 ESPORTS, INC.
| CASTLE CREEK PHARMACEUTICAL HOLDINGS, INC.
| KEENWAWA, INC.
| PARAGON BIOSCIENCES EMALEX CAPITAL, INC.
| EVOZYNE, LLC
| VALOR EQUITY PARTNERS V-A L.P.
| VALOR EQUITY PARTNERS V L.P.
| VALOR EQUITY PARTNERS V-B L.P.
| K HEALTH, INC.
| EVOZYNE, INC.
| EIGHT SLEEP INC.
| VALOR SIREN VENTURES II L.P.
| VALOR EQUITY PARTNERS OPPORTUNITY FUND I-B L.P.
| VALOR EQUITY PARTNERS OPPORTUNITY FUND I-A L.P.
| VALOR EQUITY PARTNERS OPPORTUNITY FUND I L.P.
| VALOR EQUITY PARTNERS VI-A L.P.
| VALOR EQUITY PARTNERS VI L.P.
| VALOR EQUITY PARTNERS VI-B L.P.
| CIRC BIOSCIENCES, INC.
| VGX 1.0 L.P.
| MAGIC SCHOOL, INC.
| CASTLE CREEK BIOSCIENCES, INC.
| VALOR ATREIDES AI I L.P.
| VALOR ATREIDES AI I-B L.P.
| VALOR COMPUTE INFRASTRUCTURE L.P.
| VALOR CI BLOCKER FEEDER L.P.
ANTONIO
J.
GRACIAS
DIRECTOR
W.
BRADFORD
MIDDLEKAUFF
EXECUTIVE OFFICER
PATRICK
MORRIS
EXECUTIVE OFFICER, DIRECTOR
CASTLE CREEK PHARMACEUTICALS, LLC
| HARMONY BIOSCIENCES II, INC.
| PARAGON BIOSCIENCES EMALEX CAPITAL, INC.
| PARAGON BIOSCIENCES SKYLINE CAPITAL, LLC
| CASTLE CREEK PHARMACEUTICAL HOLDINGS, INC.
| NORDAQ ENERGY INC.
| BINOVI TECHNOLOGIES CORP.
| CIRC BIOSCIENCES, INC.
| CASTLE CREEK BIOSCIENCES, INC.
PATRICK
J.
MORRIS
EXECUTIVE OFFICER, DIRECTOR
DARIEN
PARHAD
EXECUTIVE OFFICER
HARMONY BIOSCIENCES II, INC.
| PARAGON BIOSCIENCES EMALEX CAPITAL, INC.
| PARAGON BIOSCIENCES QLARITY CAPITAL, INC.
| EVOZYNE, LLC
| PARAGON BIOSCIENCES EVOZYNE HOLDINGS, LLC
| PARAGON BIOSCIENCES EVOZYNE CAPITAL, LLC
| CIRC BIOSCIENCES, INC.
| PARAGON BIOSCIENCES CIRC HOLDINGS, LLC
| EVOZYNE, INC.
| CASTLE CREEK BIOSCIENCES, INC.
GREGORY
WUJEK
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-04-19
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2022-01-18
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2021-06-28
